Groton Economic Development: Groton Biotech Firm Working On Much-Needed Drug To Treat Stroke, Brain Injuries

Groton CT

04 December, 2021

5:31 AM

Description

Press release from Groton Economic Development: December 2, 2021 A small drug development company that moved its headquarters from Cambridge, Mass., to the BioCT Innovations Commons on Shennecossett Road last year is aiming to have a huge impact on the treatment of strokes and brain injuries. Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022. Last week, Astrocyte put out word that Stroke, a peer-reviewed journal, had published the results of preclinical studies of the drug, known for now as AST-004. Click here for the full article This press release was produced by Groton Economic Development. The views expressed here are the author's own.